Merck Manual

Please confirm that you are a health care professional

honeypot link

FDA Warns Consumers About Products Containing CBD

12/09/19 By
Merck Veterinary Manual

FDA has warned consumers that although products containing CBD (cannabidiol) are widely available, they may not be safe. While the agency is working to "answer questions about the science, safety, and quality of products containing cannabis, and cannabis-derived compounds including CBD," much remains uncertain.

FDA is concerned that people taking CBD may have adverse effects, including liver injury, effects on the metabolism of other drugs, and increased sedation or drowsiness if taken with other drugs such as alcohol or other CNS depressants.

The agency has approved CBD for only one use so far, a prescription medication for a rare form of epilepsy. FDA noted that it is currently illegal to market CBD by adding it to a food or dietary supplement. No uses have been approved for animals. Among other issues, FDA is investigating the safety of CBD in animals, including both pets and food-producing animals.

FDA has also issued warning letters to 15 companies, telling them that they are violating federal law by adding CBD to human foods, nutritional supplements, and animal foods and for marketing unapproved human and animal drugs containing CBD.

More details on the FDA consumer warning on CBD products are available from CNBC. The full FDA announcement on CBD can be read here.

More information on the toxicity of cannabis in animals is available in the Merck Veterinary Manual.

Test your knowledge
Anthrax is a zoonotic disease affecting a broad range of species. Naturally occurring infections can cause illnesses that range from an acute, highly fatal form to a less acute and less serious clinical illness that can also be fatal. Which of the following species is most likely to develop acute fatal disease with anthrax infection?